Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today introduced its first USDA-licensed real-time PCR test to detect bovine viral diarrhea virus (BVDV), a debilitating disease that costs the U.S. cattle industry an estimated $2 billion per ... read more

Bruker Corporation (NASDAQ: BRKR) announced today at the Materials Research Society (MRS) Fall 2010 Meeting the release of a new generation of Atomic Force Microscopy (AFM) modes and measurement modules that transform Bruker’s AFM systems into turnkey solutions for nanoscale characterization in renewable energy research. The ... read more

Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris’ ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced positive top-line data from a 48-week phase 3 long-term safety and efficacy clinical trial of lubiprostone in Japanese patients with chronic idiopathic constipation (CIC). The trial demonstrated that lubiprostone was safe and well-tolerated. ... read more

Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the “Outstanding Scientific Achievement” award from the Defense Threat Reduction Agency (DTRA). The award was presented at the 2010 Chemical and Biological Defense Science and Technology Conference in Orlando, Florida to Dr. Justin Skoble, Associate Director, ... read more

Dow Brazil, global giant in the chemical and plastics sectors with operations in Brazil since 1956, announced at FEIPLAR COMPOSITES & FEIPUR – International Trade Show and Congresses of Composites, Polyurethanes and Engineering Plastics – the Technology and Market Development Center for Polyurethanes and Formulated Systems ... read more

An article published recently in Psychosomatic Medicine 72:(November) 897-904) showed that the Williams LifeSkills video training program can reduce stress in individuals who care for a relative with Alzheimer’s disease. The impact of the 5-week video training was significant: depressive symptoms, perceived stress, anxiety and blood ... read more

Apricus Biosciences, Inc. (“Apricus Bio”) (NASDAQ: APRI), announced today that the International Journal of Pharmaceutics, a peer reviewed journal, has published new data on the NexACT® technology in their November 2010 issue, based on research conducted by, and at, the Ernest Mario School of Pharmacy, Rutgers-The ... read more

Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging, announced today that it is exhibiting its CTLM system at the 96th RSNA 2010 Scientific Assembly and Annual Meeting, November 29th – December 2nd in Chicago, Illinois. The company is located at booth #4419 ... read more

CEA-Leti announced today the first infrared imaging array in the 8-10µm band capable of returning an image with a record-breaking minimum temperature difference, or thermal resolution, of 1 to 2mK at ambient temperature and with traditional image cadences of 25-50 Hertz. ... read more

Quintiles, the world’s leading biopharmaceutical services company, and London Genetics, an expert in the use of pharmacogenetics in drug discovery and development, today announced a strategic alliance to offer the biopharmaceutical industry innovative pharmacogenetics solutions to advance personalized medicine. Financial ... read more

InnovoCommerce, LLC released the market leading innovoPOINT® 3.1 clinical and investigator portal solution for life science organizations. This solution, built on the Microsoft® SharePoint® platform, is used for secure document exchange, clinical trial business process automation and the streamlining of communications between ... read more

As people live longer and advance in age, the incidence of several types of chronic and acute pain will increase significantly, driving growth in transdermal pain drug products at 9.8% CAGR over the next five years, reaching $9.2 billion by 2015, according to the latest estimates from ... read more

SuperSonic Imagine’s historical investors, Edmond de Rothschild Investment Partners, Auriga Partners, Crédit Agricole Private Equity, NBGI Ventures, BioAm (managed by CDC Entreprises), Wellington Partners and IXO Private Equity, reiterated their strong support through a combined investment of €19 million in this round. ... read more

Zalicus Inc. (NASDAQ: ZLCS) announced today that preclinical data on its discovery of novel A2A agonist oncology programs for the treatment of multiple myeloma and other B-cell malignancies will be highlighted at the 52nd Annual Meeting of the American Society of Hematology in Orlando, FL on ... read more

Calistoga Pharmaceuticals, Inc., the leader in the development of delta-isoform-selective phosphatidylinositol 3-kinase (PI3K-delta) inhibitors for the treatment of cancer and inflammatory diseases, today announced the upcoming presentation of clinical and preclinical results supporting the clinical benefit of CAL-101, an oral, PI3K-delta ... read more

Avila Therapeutics™, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug. In the paper titled “Selective Irreversible ... read more

Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the launch of its next-generation Qubit® 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that require a large financial or time investment. The new ... read more

An interview with Dr. Sam Stupp, founder and scientific advisor to Nanotope, Inc., an Arrowhead (NASDAQ: ARWR) portfolio company, was broadcast by the BBC World Service on November 28, 2010. In the interview, Dr. Stupp describes and discusses the regenerative medicine platform being developed by Nanotope, ... read more

Nanostart (OTCQX:NASRY)-holding Nanosys has entered into a distribution agreement with multi-billion dollar concern Sigma-Aldrich (Nasdaq: SIAL). Under the agreement, Sigma-Aldrich, through its Aldrich Material Science business, is now distributing Nanosys-created silicon nanowires to the global scientific research community for the development of new ... read more